Federally funded research in hepatology
Jenny Heathcote – 5 January 2004
Jenny Heathcote – 5 January 2004
Jinah Choi, Ki Jeong Lee, Yanyan Zheng, Ardath K. Yamaga, Michael M.C. Lai, Jing‐hsiung Ou – 5 January 2004 – Hepatitis C virus (HCV) is a positive‐stranded RNA virus that causes severe liver diseases, such as cirrhosis and hepatocellular carcinoma. HCV uses an RNA‐dependent RNA polymerase to replicate its genome and an internal ribosomal entry site to translate its proteins. HCV infection is characterized by an increase in the concentrations of reactive oxygen species (ROS), the effect of which on HCV replication has yet to be determined.
Hiroaki Shibahara, Shugo Tamada, Michiyo Higashi, Masamichi Goto, Surinder K. Batra, Michael A. Hollingsworth, Kohzoh Imai, Suguru Yonezawa – 5 January 2004 – Complete surgical resection of the tumor is the sole approach to improve the cure rate of patients with intrahepatic cholangiocarcinoma‐mass forming type (ICC‐MF). Although patients are treated by curative resection, many of them show poor outcome.
Patrick L. Splinter, Anatoliy I. Masyuk, Raul A. Marinelli, Nicholas F. LaRusso – 5 January 2004 – Rodent cholangiocytes express 6 of the 11 known channel proteins called aquaporins (AQPs) that are involved in transcellular water transport in mammals. However, clarifying the role of AQPs in mediating water transport in biliary epithelia has been limited in part because of the absence of physiologically relevant experimental models.
Karine Hellemans, Peggy Verbuyst, Erik Quartier, Frans Schuit, Krista Rombouts, Ross A.S. Chandraratna, Detlef Schuppan, Albert Geerts – 5 January 2004 – Activation of hepatic stellate cells (HSC) is a central event in the pathogenesis of liver fibrosis during chronic liver injury. We examined the expression of retinoic acid (RAR) and retinoid X receptors (RXR) during HSC activation and evaluated the influence of natural and synthetic retinoic acids (RA) on the phenotype of culture‐activated HSC.
Antonello Pietrangelo – 5 January 2004
Francis Y. Yao, Sammy Saab, Nathan M. Bass, Ryutaro Hirose, David Ly, Norah Terrault, Ann A. Lazar, Peter Bacchetti, Nancy L. Ascher, John P. Roberts – 5 January 2004 – The current policy for determining priority for organ allocation is based on the model for end stage liver disease (MELD). We hypothesize that severity of graft dysfunction assessed by either the MELD score or the Child‐Turcotte‐Pugh (CTP) score correlates with mortality after liver retransplantation (re‐OLT).
Olav Dalgard, Atle Egeland, Kjell Skaug, Kostas Vilimas, Tore Steen – 5 January 2004 – This study assessed the effect of chronic hepatitis C virus (HCV) infection on the health‐related quality of life (HRQOL) of injecting drug users, comparing the HRQOL of injecting drug users with and without chronic HCV infection. The study included 199 injecting drug users of more than 18 years of age who participated in a needle exchange program. Blood samples were tested for the presence of HCV RNA in serum with a polymerase chain reaction method.
Gennaro D'Amico, Alberto Morabito – 5 January 2004
Hyam L. Leffert, Stewart Sell – 5 January 2004